Literature DB >> 16323076

The expression and alternative splicing of alpha-neurexins during Xenopus development.

Zhihong Zeng1, Colin R Sharpe, J Paul Simons, Dariusz C Górecki.   

Abstract

The neurexins are involved in the formation and function of synapses. Each of three genes encodes alpha- and beta-neurexins. Additional diversity (particularly of alpha-neurexins) arises from alternative splicing, resulting in a large number of protein isoforms, the significance of which is currently unclear. We have analysed alpha neurexin expression and alternative splicing during development of the frog Xenopus laevis. Surprisingly, each alpha-neurexin gene is expressed in immature oocytes. During embryonic development, each Xenopus neurexin (nrxn) gene has a distinct temporal expression pattern, with expression being almost exclusively within the neuroepithelium. The spatial expression of nrxnIalpha and nrxnIIalpha is similar in the developing CNS, with staining being observed in the optic cup and in dorsolateral regions of anterior neural tube, but not adjacent to the ventral midline. The pattern of nrxnIIIalpha expression is more restricted, in several domains of the anterior neural tube. In the forebrain, expression was confined to an area in the ventrolateral neural tube; nrxnIIIalpha was also expressed in the hindbrain and spinal cord. By stage 32, a period when synaptogenesis occurs, nrxnIIIalpha is expressed midway along the neural tube's dorso-ventral axis in the hindbrain and anterior spinal cord, at the site of the primary interneuron column. Because of the striking diversity of neurexin isoforms, we analysed alternative splicing of Xenopus transcripts during development and found examples of alternative splice variants of each neurexin. The data demonstrate differential regulation of the alpha neurexins with respect to the gene temporal and spatial expression and alternative splicing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16323076     DOI: 10.1387/ijdb.052068zz

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  11 in total

1.  Crystal structure of the second LNS/LG domain from neurexin 1alpha: Ca2+ binding and the effects of alternative splicing.

Authors:  Lauren R Sheckler; Lisa Henry; Shuzo Sugita; Thomas C Südhof; Gabby Rudenko
Journal:  J Biol Chem       Date:  2006-06-13       Impact factor: 5.157

2.  Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing.

Authors:  Barbara Treutlein; Ozgun Gokce; Stephen R Quake; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

3.  Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions.

Authors:  Christian P Schaaf; Philip M Boone; Srirangan Sampath; Charles Williams; Patricia I Bader; Jennifer M Mueller; Oleg A Shchelochkov; Chester W Brown; Heather P Crawford; James A Phalen; Nicole R Tartaglia; Patricia Evans; William M Campbell; Anne Chun-Hui Tsai; Lea Parsley; Stephanie W Grayson; Angela Scheuerle; Carol D Luzzi; Sandra K Thomas; Patricia A Eng; Sung-Hae L Kang; Ankita Patel; Pawel Stankiewicz; Sau W Cheung
Journal:  Eur J Hum Genet       Date:  2012-05-23       Impact factor: 4.246

4.  Induction of GABAergic postsynaptic differentiation by alpha-neurexins.

Authors:  Yunhee Kang; XueZhao Zhang; Frederick Dobie; Huaiyang Wu; Ann Marie Craig
Journal:  J Biol Chem       Date:  2007-11-15       Impact factor: 5.157

5.  Neurexins physically and functionally interact with GABA(A) receptors.

Authors:  Chen Zhang; Deniz Atasoy; Demet Araç; Xiaofei Yang; Marc V Fucillo; Alfred J Robison; Jaewon Ko; Axel T Brunger; Thomas C Südhof
Journal:  Neuron       Date:  2010-05-13       Impact factor: 17.173

6.  Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.

Authors:  Michael S L Ching; Yiping Shen; Wen-Hann Tan; Shafali S Jeste; Eric M Morrow; Xiaoli Chen; Nahit M Mukaddes; Seung-Yun Yoo; Ellen Hanson; Rachel Hundley; Christina Austin; Ronald E Becker; Gerard T Berry; Katherine Driscoll; Elizabeth C Engle; Sandra Friedman; James F Gusella; Fuki M Hisama; Mira B Irons; Tina Lafiosca; Elaine LeClair; David T Miller; Michael Neessen; Jonathan D Picker; Leonard Rappaport; Cynthia M Rooney; Dean P Sarco; Joan M Stoler; Christopher A Walsh; Robert R Wolff; Ting Zhang; Ramzi H Nasir; Bai-Lin Wu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

7.  New insights into molecular pathways associated with flatfish ovarian development and atresia revealed by transcriptional analysis.

Authors:  Angèle Tingaud-Sequeira; François Chauvigné; Juanjo Lozano; María J Agulleiro; Esther Asensio; Joan Cerdà
Journal:  BMC Genomics       Date:  2009-09-15       Impact factor: 3.969

8.  Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression.

Authors:  Chelsea Lowther; Marsha Speevak; Christine M Armour; Elaine S Goh; Gail E Graham; Chumei Li; Susan Zeesman; Malgorzata J M Nowaczyk; Lee-Anne Schultz; Antonella Morra; Rob Nicolson; Peter Bikangaga; Dawa Samdup; Mostafa Zaazou; Kerry Boyd; Jack H Jung; Victoria Siu; Manjulata Rajguru; Sharan Goobie; Mark A Tarnopolsky; Chitra Prasad; Paul T Dick; Asmaa S Hussain; Margreet Walinga; Renske G Reijenga; Matthew Gazzellone; Anath C Lionel; Christian R Marshall; Stephen W Scherer; Dimitri J Stavropoulos; Elizabeth McCready; Anne S Bassett
Journal:  Genet Med       Date:  2016-05-19       Impact factor: 8.822

9.  Transcriptomic analysis of maternally provisioned cues for phenotypic plasticity in the annual killifish, Austrofundulus limnaeus.

Authors:  Amie L Romney; Jason E Podrabsky
Journal:  Evodevo       Date:  2017-04-21       Impact factor: 2.250

10.  Short linear motif acquisition, exon formation and alternative splicing determine a pathway to diversity for NCoR-family co-repressors.

Authors:  Stephen Short; Tessa Peterkin; Matthew Guille; Roger Patient; Colin Sharpe
Journal:  Open Biol       Date:  2015-08       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.